Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH.

Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH.
复制标题

DOI:
10.1111/jth.15074
复制
发表时间:
2020-12
期刊:
Journal of thrombosis and haemostasis : JTH
影响因子:
--
通讯作者:
Zwicker JI
Zwicker JI
中科院分区:
其他
文献类型:
--
作者:
Wang TF;Makar RS;Antic D;Levy JH;Douketis JD;Connors JM;Carrier M;Zwicker JI

文献摘要

参考文献

被引文献

相似文献

急性白血病患者经常发生血小板减少和凝血功能障碍引起的止血并发症。凝血障碍使这些患者的管理复杂化,并可导致显著的发病率和死亡率。本指南文件旨在审查急性白血病成人患者止血并发症的管理并提供指导,解决四个主要问题,包括血小板输注、弥散性血管内凝血、L-天冬酰胺酶相关的低纤维蛋白原血症和抗纤溶药物的使用。
Patients with acute leukemia frequently develop thrombocytopenia and hemostatic complications caused by coagulopathy. Coagulopathy complicates the management of these patients and can lead to significant morbidity and mortality. This guidance document aims to review and provide guidance on the management of hemostatic complications in adult patients with acute leukemia, addressing four main issues, including platelet transfusion, disseminated intravascular coagulation, L-asparaginase-related hypofibrinogenemia, and the use of antifibrinolytic agents.
DOI: 10.1080/10428190500102662
发表时间: 2005-08-01
影响因子: 2.6
作者:
Higuchi, T;Toyama, D;Omine, M
通讯作者: Omine, M
DOI: 10.1038/leu.2011.78
发表时间: 2011-07-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Lehmann, S.;Ravn, A.;Juliusson, G.
通讯作者: Juliusson, G.
DOI: 10.1016/j.bcmd.2019.102351
发表时间: 2019-11-01
影响因子: 2.3
作者:
Hou, Wenyi;Zhang, Yingmei;Zhou, Jin
通讯作者: Zhou, Jin
DOI: 10.1097/01.ccm.0000202209.42491.38
发表时间: 2006-03-01
影响因子: 8.8
作者:
Gando, S;Iba, T;Shimazaki, S
通讯作者: Shimazaki, S
DOI: 10.3324/haematol.12948
发表时间: 2008-10-01
期刊: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
影响因子: --
作者:
Hunault-Berger, Mathilde;Chevallier, Patrice;Gruel, Yves
通讯作者: Gruel, Yves